EGFR is upregulated in 35~70% of epithelial ovarian cancers and the enhanced EGFR signaling pathway has been closely linked with the development of an invasive phenotype in various ovarian cancer cell types [52]. The gene discussed is EGFR; the disease is ovarian carcinoma.